Specifically, the plasma protein TCL1A (TCL1 family AKT coactivator A), which is uniquely expressed by B cells and associated with B-cell maturation75, is modulated by polygenic risks; furthermore, its plasma level is altered in patients with AD compared with that in NCs (Fig. 5e, f). This evidence concerns the gene TCL1A and Alzheimer disease.